Develops in-body gene editing technology to modify blood stem cells, creating single-treatment solutions for diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Ensoma is a biotechnology company developing genomic medicines that engineer hematopoietic stem cells (HSCs) directly within the body. Their platform combines in vivo delivery systems with advanced gene editing tools to create one-time treatments for various diseases.
Ensoma Funding
Sign up to gain insights into Ensoma funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series B | Sep 22, 2025 | 45M | ||
| Series B | May 22, 2023 | 8M | ||
| Series B | May 16, 2023 | 50M | ||
| Series B | Jan 05, 2023 | 6M | ||
| Series B | Dec 23, 2022 | 79M | ||
| Series A | Oct 28, 2021 | 30M | ||
| Series A | Feb 05, 2021 | 11M | ||
| Series A | Feb 05, 2021 | 30M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Ensoma Management Team
Investors
The Bill & Melinda Gates Foundation
SymBiosis II
Solasta Ventures
Qatar Investment Authority (QIA)
Mirae Asset Capital
Kite Ventures
F-Prime Capital
Delos Capital
Cormorant Asset Management
Catalio Capital Management
Bioluminescence Ventures
Arix Bioscience
5AM Ventures
Ensoma Valuations & Financials
View real-time NPM data on Ensoma stock including daily Ensoma stock price estimates, valuation history, and historical share price information. Access Ensoma financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Ensoma pricing across six independent market signals. Looking for private company due diligence data sources on Ensoma? Get in touch to learn more.
Similar Companies
like Ensoma
FAQ
We have answers
Ensoma stock does not trade on public stock exchanges. Ensoma stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Ensoma stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Ensoma Stock does not trade on public stock exchanges. In order to sell Ensoma shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Ensoma does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Ensoma share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Ensoma stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Ensoma stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Ensoma stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Ensoma is a private company and has not had an IPO. There is currently no Ensoma IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Ensoma IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
